Anti-inflammatory activity of superoxide dismutase obtained from Debaryomyces hansenii on type II collagen induced arthritis in rats

Revista de Investigacion Clinica

Volumn 61, Issue 3, 2009, Pages 212-220

  García González, Adolfo ^a,d   Lotz, Martin ^b   Ochoa, Jose L ^c  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c CENTRO DE INVESTIGACIONES BIOLÓGICAS DEL NOROESTE   (Mexico)

^d NONE   (Mexico)

Author keywords

Collagen induced arthritis; Debaryomyces hansenii; Rat; Anti inflammatory activity; Superoxide dismutase

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; COPPER ZINC SUPEROXIDE DISMUTASE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; COW; DEBARYOMYCES HANSENII; DISEASE SEVERITY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; HISTOPATHOLOGY; LOW DRUG DOSE; NONHUMAN; RAT; RHEUMATOID ARTHRITIS;

EID: 70349194750     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Harris EDJr. Mechanisms of disease: rheumatoid arthritis-pathophysiology and implications for therapy. N Engl J Med 1990; 322: 1277-1289
2. Mitchel DM. Epidemiology. In: Utzinger PD, Zvaifler NJ, Ehrlich GE (eds.). Rheumatoid Arthritis, Etiology, Diagnosis, Management. Philadelphia: JB Lippincott Co; 1985, p. 133-150
3. Andriopolous NA, Bennett JC, Mestecky J, et al. The occurrence of antibodies against human collagen in synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 1975; 18: 384-390
4. Trentham DE, Towens AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977; 146: 857-868
5. Trentham DE, Towens AS, Kang AH, David JR. Humoral and cellular sensitivity to collagen in type II collagen induced arthritis in rats. J Clin Invest 1978; 61: 89-96.
6. Cannon GW, Openshaw SJ, Hibbs JB, et al. Nitric oxide production during adjuvant induced and collagen induced arthritis. Arthritis Rheum 1996; 39: 1677-1684
7. Griffiths MM, Eichwald EJ, Martin JH, et al. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum 1981; 24: 781-789
8. Sloboda AE, Birnbaunm JE, Oronsky AL, Kerwar SS. Studies on type II collagen-induced polyarthritis in rats. Effect of antiinflammatory and antirheumatic agents. Arthritis Rheum 1981; 24: 616-624
9. McCord JM. Mechanisms of disease. Oxygen derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163
10. Cross CE. Davis conference. Oxygen radicals and human disease. Ann Inter Med 1987; 107: 526-545
11. Greenwald RA. Oxygen radicals, inflammation, and arthritis: Pathophysiological considerations and implications for treatment. Sem Arthr Rheum 1991; 20: 219-240
12. Reilly PM, Schiller HJ, Buckley G. Pharmacology approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surgery 1991; 161: 488-503.
13. Ochoa JL, Ramirez-Orozco M, Hernandez-Saavedra NY, Hernandez-Saavedra D. Halotolerant yeast Debaryomyces hansenii as an alternative source of Cu/Zn superoxide dismutase (SOD). J Marine Biotech 1995; 3: 224-227
14. Hernandez-Saavedra NY, Ochoa JL. Copper-Zinc superoxide dismutase from the marine yeast Debaryomyces hansenii. Yeast 1999; 15: 657-668 (Pubitemid 29286546)
15. Kakimoto K, Kojima Y, Ishii K, et al. The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen induced arthritis in mice. Clin Exp Immunol 1993; 94: 241-246 (Pubitemid 23337821)
16. Beauchamp C, Gilbertsen RB, Fantone J, Menapace DP. Disease modifying activity of superoxide dismutase in collagen induced arthritis in the rat. FASEB 1983 Abstracts 67th annual meeting 6354.
17. Hunt DW, Corson L, Braker H, et al. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat. J Autoimm 1993; 6: 691-700. (Pubitemid 24040924)
18. Courtenay JS, Dallman MJ, Dayan SD, et al. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980; 283: 666-668 (Pubitemid 10099994)
19. Cooper WO, Fava RA, Gates CA, et al. Acceleration of onset of collagen induced arthritis by intra-articular injection of tumor necrosis factor or transforming growth factor beta. Clin Exp Immunol 1992; 89: 244-250
20. Larsson P, Kleinau S, Holmdahl R, et al. Homologous type II collagen induced arthritis in rats. Arthritis Rheum 1990; 33: 693-701.
21. Durie FH, Fava RA, Noelle RJ. Collagen induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 1994; 73: 11-18
22. Smith SR, Pennline KJ, Bober LA, et al. Inhibition of collagen II induced arthritis in mice. A comparison effects of SCH 24937, immunosuppressant, and non-steroideal anti-inflammatory drugs on clinical expression of disease. Int J Immunopharmac 1990; 12: 165-173
23. 2 plus Cu,Zn superoxide dismutase reflects the activity of free copper released from oxidatively damaged enzyme. J Biol Chem 1992; 267: 25371-25377
24. Jasin HE, Noyori K, Tagaki T, et al. Characterization of antitype II collagen antibodies binding to articular cartilage. Arthritis Rheum 1993; 36: 651-659 (Pubitemid 23149913)
25. Greenwald RA. Oxygen radicals, inflammation and arthritis: pathophysiological considerations and implications for treatment. Sem Arthr Rheum 1991; 20: 219-240
26. Suzuki YJ, Forman HJ, Sevanian A. Oxidants as stimulators of signal transduction. Free Rad Biol Med 1997; 22: 269-285
27. Oyanagui Y. Steroid-like anti-inflammatory effect of superoxide dismutase in serotonin-, histamine-, and kinin-induced edemata of mice: existence of vascular permeability regulating protein(s). Biochem Pharmacol 1981; 30: 1791-1798 (Pubitemid 11122702)
28. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004; 6: 265-278
29. Hayashi M, Matsunaga K, Okahara A, et al. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats. J Rheumatol 1991; 18: 691-695
30. Das UN. Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases. Prostaglandins Leukotrienes Fatty Acids 1991; 44: 201-210